Breast Friends Fund (BFF)
Dr. Winer received his MD from Yale University in 1983, and later completed training in internal medicine and served as chief resident at Yale-New Haven Hospital. 

He subsequently was a fellow in hematology-oncology at Duke University Medical Center, and from 1989 to 1997 served on the Duke faculty, where he became codirector of the multidisciplinary breast program.

​ In 1997, he joined Brigham and Women's Hospital and Dana-Farber, where he is director of the Breast Oncology Center.


Physician

Chief Clinical Strategy Officer
Chief, Division of Women's Cancers
Senior Vice President for Medical Affairs
Chief, Division of Breast Oncology Center, Susan F. Smith Center for Women's Cancers
Thompson Chair in Breast Cancer Research
Institute Physician
Professor of Medicine, Harvard Medical School

100 % of Funds Go To

Metastatic Breast Cancer Research

Sandy's Story

Sandy interviewed on WTNH, Hartford, October 2018

BREAST  FRIENDS  FUND(BFF)


​​Thanks to All for Your Support in Helping us Reach Over $200,000 in Total Contributions for Research!


Who is Dr. Eric Winer ?

Sandy was initially diagnosed with Stage 3 breast cancer at the age of 37, on May 30, 2013. 


She chose to have a bilateral mastectomy followed by 8 rounds of chemotherapy and 28 rounds of radiation. 


Soon after the end of radiation treatment Sandy was declared cancer-free. 


Unfortunately, in April 2015, Sandy was no longer a breast cancer survivor.  Sandy was told that the breast cancer had spread to her liver and she was now living with Stage 4  Metastatic Breast Cancer with no cure.


After being on FDA approved treatment for 3 years in July 2018 Sandy was told her cancer is growing & she needed to find a new treatment.

Sandy is currently
enrolled in a clinical trial at Dana-Farber Cancer
Institute.



 


What is Metastatic Breast Cancer ?

Who is Dr. Eric Winer ?




Sandy Cassanelli, with her daughter, Samantha (16), her husband Craig, and her daughter Amanda (12)

Metastatic Breast Cancer Facts*:


  • 1 out of 4 people initially diagnosed with early stage breast cancer will develop Metastatic  Breast Cancer
  • Metastatic breast cancer accounts for app 40,000 death in the United States annually
  • Currently, only 7% of all Breast Cancer Research funding is allocated to Metastatic Breast Cancer Research
  • 113 women die daily from Metastatic breast cancer
  • Currently there is NO Cure for Metastatic Breast Cancer

*Metastatic Breast Cancer Network  


When breast cancer spreads to other parts of the body, such as the bones, brain, liver, or lungs, it is called metastatic (also referred to as advanced or stage IV).

Although it is not curable, metastatic breast cancer can be treatable. Today, with new therapies, including biologic targeted treatments and novel drug combinations, women with metastatic breast cancer can live well for many years.